Lundbeck to buy Chelsea Therapeutics for up to $658M

|About: Chelsea Therapeutics Inte... (CHTP)|By:, SA News Editor

Chelsea Therapeutics (CHTP) has agreed to sell itself to Lundbeck (HLUKF) for as much as $658M, with the offer of up to $7.94 a share representing a premium of 59% over Chelsea's closing price yesterday of $5. (PR)